Literature DB >> 28993008

PIWI family emerging as a decisive factor of cell fate: An overview.

Murugavel Ponnusamy1, Kao-Wen Yan1, Cui-Yun Liu1, Pei-Feng Li1, Kun Wang2.   

Abstract

PIWI proteins and piRNAs primarily functions as a safeguard of germline cells by activating epigenetic regulations, silencing transposons and maintaining chromatin structure. Increasing evidences reveal that PIWI proteins and piRNAs have broader functions in many vital biological processes including cell proliferation, differentiation and survival. They have been recognized as a crucial factor in the cellular events due their role in controlling mRNA expression, turnover and translation. PIWIs, with or without its partner non-coding RNA (piRNA), govern the expression and activity of many transcription factors and signaling molecules by mastering their expression and/or post-translational modifications by directly interacting with them. In this review, we focus on the functional role of PIWI family of proteins and piRNA in physiological and pathological conditions. We compile the current knowledge about the impact of alterations of PIWI and/or piRNA on expression and activities of signaling mediators and transcriptional networks associated with cell differentiation, proliferation and survival.
Copyright © 2017. Published by Elsevier GmbH.

Entities:  

Keywords:  Anti-apoptotic genes; Cyclin inhibitors; Cyclins; PIWIL; Pro-survival signaling

Mesh:

Substances:

Year:  2017        PMID: 28993008     DOI: 10.1016/j.ejcb.2017.09.004

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  15 in total

1.  The RNA landscape of the human placenta in health and disease.

Authors:  Gordon C S Smith; D Stephen Charnock-Jones; Sungsam Gong; Francesca Gaccioli; Justyna Dopierala; Ulla Sovio; Emma Cook; Pieter-Jan Volders; Lennart Martens; Paul D W Kirk; Sylvia Richardson
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

2.  PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat.

Authors:  Zhangping He; Shuliang Jing; Tao Yang; Jingliang Chen; Feng Huang; Wanying Zhang; Zhilin Peng; Bingfeng Liu; Xiancai Ma; Liyang Wu; Ting Pan; Xu Zhang; Linghua Li; Weiping Cai; Xiaoping Tang; Junsong Zhang; Hui Zhang
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

Review 3.  Noncoding RNAs in Alzheimer's disease.

Authors:  M Laura Idda; Rachel Munk; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-01-12       Impact factor: 9.957

Review 4.  Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.

Authors:  Zhixia Zhou; Zhan Wang; Jie Gao; Zhijuan Lin; Yin Wang; Peipei Shan; Mengkun Li; Tingting Zhou; Peifeng Li
Journal:  Mol Ther Oncolytics       Date:  2022-03-16       Impact factor: 6.311

Review 5.  Functional Interplay between Small Non-Coding RNAs and RNA Modification in the Brain.

Authors:  Laura J Leighton; Timothy W Bredy
Journal:  Noncoding RNA       Date:  2018-06-07

6.  Non-coding RNAome of RPE cells under oxidative stress suggests unknown regulative aspects of Retinitis pigmentosa etiopathogenesis.

Authors:  Luigi Donato; Concetta Scimone; Carmela Rinaldi; Rosalia D'Angelo; Antonina Sidoti
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

7.  PIWI proteins contribute to apoptosis during the UPR in human airway epithelial cells.

Authors:  Magdalena Gebert; Sylwia Bartoszewska; Anna Janaszak-Jasiecka; Adrianna Moszyńska; Aleksandra Cabaj; Jarosław Króliczewski; Piotr Madanecki; Renata J Ochocka; David K Crossman; James F Collawn; Rafal Bartoszewski
Journal:  Sci Rep       Date:  2018-11-06       Impact factor: 4.379

Review 8.  RNA 2'-O-Methylation (Nm) Modification in Human Diseases.

Authors:  Dilyana G Dimitrova; Laure Teysset; Clément Carré
Journal:  Genes (Basel)       Date:  2019-02-05       Impact factor: 4.096

9.  Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases.

Authors:  Bram Verstockt; Sare Verstockt; Marisol Veny; Jonas Dehairs; Kaline Arnauts; Gert Van Assche; Gert De Hertogh; Séverine Vermeire; Azucena Salas; Marc Ferrante
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-22       Impact factor: 11.382

Review 10.  ALUminating the Path of Atherosclerosis Progression: Chaos Theory Suggests a Role for Alu Repeats in the Development of Atherosclerotic Vascular Disease.

Authors:  Miguel Hueso; Josep M Cruzado; Joan Torras; Estanislao Navarro
Journal:  Int J Mol Sci       Date:  2018-06-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.